Isabell Bludau

Isabell Bludau is head of bioinformatics and junior group leader at the Department of Neuropathology at Heidelberg University Hospital. She earned her PhD in computational proteomics from ETH Zurich in the group of Prof. Ruedi Aebersold, focusing on algorithm development for proteoform and protein complex inference from mass spectrometry data. Following her doctoral work, she completed a postdoctoral fellowship in the lab of Prof. Matthias Mann at the Max Planck Institute of Biochemistry in Munich, focusing on the integration of proteomics with structural predictions from AI tools such as AlphaFold. Isabell Bludau currently leads a team investigating inter- and intra-patient molecular and functional diversity from genome to proteome level of brain cancer. She is a principal investigator in the EZN Cancer Neuroscience funding line and supervises four PhD students and one postdoctoral researcher.

Isabel research aims to unravel the molecular and functional diversity that emerges from genome to transcriptome, proteome, and phenotype—particularly in the context of brain cancer. Her group develops computational strategies rooted in both classical statistical methods and AI-based approaches to dissect inter- and intra-tumoral heterogeneity. A central focus lies in computational proteomics and multi-omics data integration, leveraging multiple ‘omics’ data layers to map molecular and phenotypic diversity. Through this systems-level lens, the group seeks to generate clinically actionable insights and biomarkers that advance precision medicine in neuro-oncology and beyond.